Drug resistance to anti-tuberculotics in children - three years status in Slovakia

1. Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, van Gemert W, Hoffner S, Rusovich V. Zignol M. Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk. Eur Respir J 2012; 39: 1425-31.10.1183/09031936.00145411Search in Google Scholar

2. Solovič I. Tuberkulóza, vybrané kapitoly. Vyšné Hágy, NÚTPCHaHCH 2008.Search in Google Scholar

3. van Rie A, Warren R, Richardson M, Gie RP, Enarson DA, Beyers N, Van Helden PD. Classification of drugresistant tuberculosis in an epidemic area. Lancet 2000; 356 (9223): 22-5.10.1016/S0140-6736(00)02429-6Search in Google Scholar

4. Rozborilová E. Tuberkulóza a mykobakteriózy. Bratislava, UK, 2009.Search in Google Scholar

5. van der Werf MJ, Langendam MW, Huitric E, Manissero D.Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis. Eur Respir J 2012; 39 (6): 1511-9.10.1183/09031936.00125711Search in Google Scholar

6. Cegielski P, Nunn P, Kurbatova EV, Weyer K, Dalton TL, Wares DF, et al. Challenges and controversies in defining totally drug-resistant tuberculosis. Emerg Infect Dis [Internet]. 2012 Nov [07.02.2013].Search in Google Scholar

7. WHO. Guidelines for the programmatic management of drug-resistant tuberculosis: Emergency Update 2008. WHO/HTM/TB/2008.402. Geneva, Switzerland: WHO, 2008.Search in Google Scholar

8. Cruz AT, Starke JR. Pediatric Tuberculosis. Pediatrics in Review 2010; 31:13-26.10.1542/pir.31.1.13Search in Google Scholar

9. Váňa J, Johanes R, Adamicová K, Žáček M. Zriedkavá príčina náhlej brušnej príhody. Slovenská chirurgia 2010; 7(1-2):12-4.Search in Google Scholar

10. Jaramillo E. Guidelines for programmatic management of drug-resistant tuberculosis. Stop TB Initiative, WHO, 2008, p. 247.Search in Google Scholar

11. Hopewell PC, Madhukar P, Maher D, Uplekar M, Raviglione MC. International Standards for Tuberculosis Care. Lancet Inf Dis 2006; 6(11): 710-25.10.1016/S1473-3099(06)70628-4Search in Google Scholar

12. Drobac PC, Mukherjee JS, Joseph JK, MItnick C, Furin JJ, del Castillo H, Shin SS, Becerra MC. Community- Based Therapy for Children With Multidrug-Resistant Tuberculosis. Pediatrics 2006; 117 (6): 2022-9.10.1542/peds.2005-223516740844Search in Google Scholar

13. Albanna AS, Menzies D. Drug-Resistant Tuberculosis: What are the Treatment Options? Drugs 2011; 71 (7): 815-25.Search in Google Scholar

14. Al-Dabbagh M, Lapphra K, McGloin R, Inrig K, Schaaf HS, Marais BJ, Sauve L, Kitai I, Kollmann TR. Drugresistant tuberculosis: pediatric guidelines. Pediatr Infect Dis J 2011; 30 (6): 501-5.10.1097/INF.0b013e31820b583d21297522Search in Google Scholar

15. Seddon JA, Hesseling AC, Marais BJ, McIlleron H, Peloquin CA, Donald PR, Schaaf HS. Paediatric use of second- line anti-tuberculosis agents: a review. Tuberculosis (Edinb) 2012; 92 (1): 9-17.10.1016/j.tube.2011.11.00122118883Search in Google Scholar

16. Porvazník I, Mokrý J, Solovič I. Actual situation in resistance to anti-tuberculotics in Slovak Republic (In Slovak). In: Čalkovská A. (ed). Novinky v experimentálnej a klinickej medicíne. Zborník. JLFUK Martin, 2012: 152-9.Search in Google Scholar

17. Bartu V, Kopecka E, Havelkova M. Factors Associated with Multidrugresistant Tuberculosis: Comparison of Patients Born Inside and Outside of the Czech Republic. The Journal of International Medical Research 2010; 38: 1156-63.10.1177/14732300100380034520819455Search in Google Scholar

18. WHO IUATALD. Anti-tuberculosis drug resistance in the world:third global report. Geneva: World Health Organization, 2004: 299.Search in Google Scholar

19. Zignol M, Hosseini MS, Wright A, Lambregts–van Weezenbeek C, Nunn P, Watt CJ, Williams BG, Dye C. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194:479–85.10.1086/50587716845631Search in Google Scholar